1. Home
  2. NTRA vs DVN Comparison

NTRA vs DVN Comparison

Compare NTRA & DVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTRA
  • DVN
  • Stock Information
  • Founded
  • NTRA 2003
  • DVN 1971
  • Country
  • NTRA United States
  • DVN United States
  • Employees
  • NTRA N/A
  • DVN N/A
  • Industry
  • NTRA Medical Specialities
  • DVN Oil & Gas Production
  • Sector
  • NTRA Health Care
  • DVN Energy
  • Exchange
  • NTRA Nasdaq
  • DVN Nasdaq
  • Market Cap
  • NTRA 27.0B
  • DVN 22.2B
  • IPO Year
  • NTRA 2015
  • DVN N/A
  • Fundamental
  • Price
  • NTRA $238.04
  • DVN $35.86
  • Analyst Decision
  • NTRA Strong Buy
  • DVN Buy
  • Analyst Count
  • NTRA 16
  • DVN 21
  • Target Price
  • NTRA $224.88
  • DVN $42.84
  • AVG Volume (30 Days)
  • NTRA 1.8M
  • DVN 8.5M
  • Earning Date
  • NTRA 11-06-2025
  • DVN 11-05-2025
  • Dividend Yield
  • NTRA N/A
  • DVN 2.68%
  • EPS Growth
  • NTRA N/A
  • DVN N/A
  • EPS
  • NTRA N/A
  • DVN 4.24
  • Revenue
  • NTRA $2,116,676,000.00
  • DVN $16,554,000,000.00
  • Revenue This Year
  • NTRA $25.70
  • DVN $12.56
  • Revenue Next Year
  • NTRA $15.42
  • DVN N/A
  • P/E Ratio
  • NTRA N/A
  • DVN $8.44
  • Revenue Growth
  • NTRA 38.17
  • DVN 13.94
  • 52 Week Low
  • NTRA $125.38
  • DVN $25.89
  • 52 Week High
  • NTRA $240.40
  • DVN $39.58
  • Technical
  • Relative Strength Index (RSI)
  • NTRA 82.14
  • DVN 62.41
  • Support Level
  • NTRA $195.14
  • DVN $34.79
  • Resistance Level
  • NTRA $212.21
  • DVN $36.13
  • Average True Range (ATR)
  • NTRA 9.35
  • DVN 1.16
  • MACD
  • NTRA 2.78
  • DVN 0.19
  • Stochastic Oscillator
  • NTRA 96.00
  • DVN 79.02

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About DVN Devon Energy Corporation

Devon Energy is an oil and gas producer with acreage in several top US shale plays. While roughly two thirds of its production comes from the Permian Basin, it also holds a meaningful presence in the Anadarko, Eagle Ford, and Bakken basins. At the end of 2024, Devon reported net proved reserves of 2.2 billion barrels of oil equivalent. Net production averaged roughly 848,000 barrels of oil equivalent per day in 2024 at a ratio of 73% oil and natural gas liquids and 27% natural gas.

Share on Social Networks: